Compare ALLO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | TLRY |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 452.6M | 533.5M |
| IPO Year | 2018 | 2018 |
| Metric | ALLO | TLRY |
|---|---|---|
| Price | $0.76 | $2.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $9.00 | $5.72 |
| AVG Volume (30 Days) | ★ 11.2M | 4.3M |
| Earning Date | 11-05-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.09 | ★ 55.69 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.44 |
| Revenue Next Year | $72.02 | $5.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.74 | $0.77 |
| 52 Week High | $4.46 | $15.70 |
| Indicator | ALLO | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 21.26 | 29.18 |
| Support Level | N/A | N/A |
| Resistance Level | $2.25 | $3.00 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 0.42 | 8.57 |
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.